MHC-BOUND, SIV-DERIVED, CTL AND HTL EPITOPES
MHC-BOUND, SIV-DERIVED, CTL AND HTL EPITOPES
批准号:
7958726
负责人:
David I Watkins
金额:
$19.66万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30
关键词:
AnimalsBindingCD4 Positive T LymphocytesCD8B1 geneChronic PhaseComputer Retrieval of Information on Scientific Projects DatabaseEpitopesFundingGaggingGrantHIVHIV SeropositivityHLA-B 2705 antigenHLA-B27 AntigenHelper-Inducer T-LymphocyteHistocompatibility Antigens Class IHumanImmune responseImmunogeneticsImmunologic Deficiency SyndromesInstitutionKnowledgeMacacaMacaca mulattaModelingNaturePeptidesPlayPositioning AttributePrimatesReagentResearchResearch PersonnelResourcesRoleServicesSourceT-LymphocyteUnited States National Institutes of HealthViralViremiaVirus ReplicationWisconsinWorkcytotoxicnovelresponsevaccine developmentvirology
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Objective: To work on developing a vaccine for HIV, we will identify additional epitopes for cytotoxic and helper T cells and use this information to develop unique reagents for following immune responses.
HLA-B27- and -B57-positive HIV-infected humans have long been associated with control of HIV replication, implying that CD8+ T cell responses contribute to control of viral replication. In a similar fashion, fifty percent of Mamu-B*08-positive Indian rhesus macaques control SIVmac239 replication and become elite controllers with chronic phase viremia below 1,000 vRNA copies/ml. Interestingly, Mamu-B*08-restricted SIV-derived epitopes appeared to match the peptide binding profile for HLA-B*2705 in humans. We, therefore, defined a detailed peptide-binding motif for Mamu-B*08 and investigated binding similarities between the macaque and human MHC class I molecules. Analysis of a panel of almost 900 peptides revealed that despite substantial sequence differences between Mamu-B*08 and HLA-B*2705, the peptide-binding repertoires of these two MHC class I molecules share a remarkable degree of overlap. Detailed knowledge of the Mamu-B*08 peptide-binding motif enabled us to identify six additional novel Mamu-B*08-restricted SIV-specific CD8+ T cell immune responses directed against epitopes in Gag, Vpr, and Env. All 13 Mamu-B*08-restricted epitopes contain an R at the position 2 primary anchor, and 10 also possess either R or K at the N-terminus. Such dibasic peptides are less prone to cellular degradation. This work highlights the relevance of the Mamu-B*08-positive SIV-infected Indian rhesus macaque as a model to examine elite control of immunodeficiency virus replication. The remarkable similarity of the peptide-binding motifs and repertoires for Mamu-B*08 and HLA-B*2705 suggests that the nature of the peptide bound by the MHC class I molecule may play an important role in control of immunodeficiency virus replication. This research used WNPRC Immunogenetics & Virology Services and Animal Services.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10422995
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10669613
-
项目类别:
-
资助金额:$97.87万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
-
批准号:10463875
-
项目类别:
-
资助金额:$98.85万
-
财政年份:2021
-
负责人:David I Watkins
-
依托单位:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
-
批准号:8787712
-
项目类别:
-
资助金额:$61.94万
-
财政年份:2014
-
负责人:David I Watkins
-
依托单位:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
-
批准号:8976140
-
项目类别:
-
资助金额:$53.0万
-
财政年份:2014
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8497605
-
项目类别:
-
资助金额:$214.55万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Protective Immunity
-
批准号:8307106
-
项目类别:
-
资助金额:$51.45万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8688135
-
项目类别:
-
资助金额:$194.7万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8301117
-
项目类别:
-
资助金额:$215.84万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
-
批准号:8874851
-
项目类别:
-
资助金额:$195.69万
-
财政年份:2012
-
负责人:David I Watkins
-
依托单位:
DEVELOPMENT OF IMMUNE MONITORING REAGENTS AND MHC TYPING TECHNOLOGIES
-
批准号:8358206
-
项目类别:
-
资助金额:$63.15万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT
-
批准号:8358204
-
项目类别:
-
资助金额:$23.83万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
IMMUNOGENICITY AND PROTECTION OF LIVE ATTENUATED SIV239 DELTA NEF IN RHESUS
-
批准号:8358203
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
MINIGENE VACCINATION WITH EARLY PRESENTED VIRAL PROTEINSAIDS RELATED RESEARCH
-
批准号:8358214
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
SIV-specific Mamu-E-restricted CD8+ T cells
-
批准号:8071437
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
CRYPTIC ORFS AS A VACCINE FOR HIV
-
批准号:8358237
-
项目类别:
-
资助金额:$5.96万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
PROTECTIVE EFFICACY OF MERCK AD5 PRIME/BOOST AGAINST MUCOSAL CHALLENGE
-
批准号:8358247
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
VACCINE REGIMENS TO INDUCE CD4+ AND CD8+ T CELLS AGAINST SIV EPITOPES
-
批准号:8358223
-
项目类别:
-
资助金额:$9.53万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
SIV-specific Mamu-E-restricted CD8+ T cells
-
批准号:8212162
-
项目类别:
-
资助金额:$21.64万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
MHC TYPING OF MACAQUES USED IN AIDS RESEARCH
-
批准号:8358202
-
项目类别:
-
资助金额:$28.59万
-
财政年份:2011
-
负责人:David I Watkins
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: